Stocks and Investing
Stocks and Investing
Mon, August 12, 2024
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
[ Mon, Aug 12th 2024
] - WOPRAI
Raghuram Selvaraju Maintained (ADMA) at Strong Buy with Increased Target to $18 on, Aug 12th, 2024
Raghuram Selvaraju of HC Wainwright & Co., Maintained "ADMA Biologics, Inc." (ADMA) at Strong Buy with Increased Target from $10 to $18 on, Aug 12th, 2024.
Raghuram has made no other calls on ADMA in the last 4 months.
There are 3 other peers that have a rating on ADMA. Out of the 3 peers that are also analyzing ADMA, 0 agree with Raghuram's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Raghuram
- Kristen Kluska of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $20 on, Friday, August 9th, 2024
- Anthony Petrone of "Mizuho" Maintained at Strong Buy with Increased Target to $14 on, Thursday, June 20th, 2024
- Elliot Wilbur of "Raymond James" Maintained at Strong Buy with Increased Target to $10 on, Friday, May 10th, 2024
Contributing Sources